<DOC>
	<DOCNO>NCT01492283</DOCNO>
	<brief_summary>The main objective study analyze pathophysiological implication glucagon incretin hormone patient liver disease ( Non alcoholic fatty liver disease ( NAFLD ) cirrhosis ) without diabetes compare healthy control . The present study contribute significantly understanding pathophysiology liver disease glucose metabolism . The final goal result could pave way new treatment modality patient liver disease .</brief_summary>
	<brief_title>Pathophysiological Implications Incretin Hormones Patients With Liver Disease With Without Diabetes</brief_title>
	<detailed_description>Comparison insulin secretion ( Area Under Curve ( AUC ) ) experimental day . Furthermore comparison GIP , GLP1 glucagon response well plasma glucose level .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
	<mesh_term>Incretins</mesh_term>
	<criteria>I ) Group 1 : NAFLD patient normal glucose tolerance Inclusion criterion NAFLD verify liver biopsy Caucasian &gt; 18 year age Negative islet cell ( ICA ) glutamic acid decarboxylase 65 ( GAD65 ) autoantibodies Normal 75g OGTT specify WHO Criteria Normal haemoglobin blood pressure ( BP ) Written inform consent II ) Group 2 : NAFLD patient type 2 diabetes Inclusion criterion NAFLD verify liver biopsy T2DM accord WHO Criteria Caucasian &gt; 18 year age Negative ICA GAD65 , normal haemoglobin , normal BP Written inform consent III ) Group 3 : NAFLD patient without type 2 diabetes Inclusion criterion NAFLD verify liver biopsy Caucasian &gt; 18 year age Normal 75g OGTT Negative ICA GAD65autoantibodies Normal haemoglobin BP Written inform consent IV ) Group 4 : Cirrhosis without type 2 diabetes Inclusion criterion Liver cirrhosis verify liver biopsy Caucasian &gt; 18 year age Negative ICA GAD65autoantibodies Normal haemoglobin BP Written inform consent V ) Group 5 : Healthy control Inclusion criterion Caucasian &gt; 18 year age Normal 75g OGTT accord WHO Criteria Negative ICA GAD65autoantibodies Normal haemoglobin BP Written inform consent Exclusion criterion ( group ) Other know liver disease viral hepatitis , hereditary haemochromatosis , autoimmune liver disease , alpha1 trypsin deficiency , Wilson disease , drug induce liver Injury ( DILI ) Treatment medication discontinue 12 hour Unwillingness participate protocol Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>NAFLD</keyword>
	<keyword>Incretin hormone</keyword>
</DOC>